A food or part of a food that allegedly provides medicinal or health benefits, including the prevention and treatment of disease. A nutraceutical may be a naturally nutrient-rich or medicinally active food, or it may be a specific component of a food, such as the omega-3 fish oil that can be derived from salmon and other cold-water fish.
麻豆原创 Analysis and Insights: Global Nutraceuticals 麻豆原创
The global Nutraceuticals market is projected to grow from US$ 326350 million in 2024 to US$ 485120 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.
The US & Canada market for Nutraceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Nutraceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Nutraceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Nutraceuticals include Amway, INFINITUS, Herbalife Nutrition, DEEJ, Usana, Blackmores, PERFECT (CHINA), Swisse and China New Era Group, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Nutraceuticals is widely used in various fields, such as Children/Teenagers, Men, Women and Pregnant Women, etc. Children/Teenagers provides greatest supports to the Nutraceuticals industry development. In 2023, global % revenue of Nutraceuticals went into Children/Teenagers filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Nutraceuticals market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Nutraceuticals, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Nutraceuticals, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nutraceuticals revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Nutraceuticals market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Nutraceuticals revenue, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Amway
INFINITUS
Herbalife Nutrition
DEEJ
Usana
Blackmores
PERFECT (CHINA)
Swisse
China New Era Group
By-health
Suntory
Pfizer
Beijing Tong Ren Tang
Shanghai Pharma
TIENS
GNC
Real Nutriceutical
Southernature
Segment by Type
Weight Management
Vitamins and Dietary Supplements
Other
Segment by Application
Children/Teenagers
Men
Women
Pregnant Women
Elderly
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Nutraceuticals in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nutraceuticals companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nutraceuticals revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Nutraceuticals 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Weight Management
1.2.3 Vitamins and Dietary Supplements
1.2.4 Other
1.3 麻豆原创 by Application
1.3.1 Global Nutraceuticals 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Children/Teenagers
1.3.3 Men
1.3.4 Women
1.3.5 Pregnant Women
1.3.6 Elderly
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nutraceuticals 麻豆原创 Perspective (2019-2030)
2.2 Global Nutraceuticals Growth Trends by Region
2.2.1 Nutraceuticals 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nutraceuticals Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Nutraceuticals Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Nutraceuticals 麻豆原创 Dynamics
2.3.1 Nutraceuticals Industry Trends
2.3.2 Nutraceuticals 麻豆原创 Drivers
2.3.3 Nutraceuticals 麻豆原创 Challenges
2.3.4 Nutraceuticals 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Nutraceuticals by Players
3.1.1 Global Nutraceuticals Revenue by Players (2019-2024)
3.1.2 Global Nutraceuticals Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Nutraceuticals 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Nutraceuticals, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Nutraceuticals 麻豆原创 Concentration Ratio
3.4.1 Global Nutraceuticals 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nutraceuticals Revenue in 2023
3.5 Global Key Players of Nutraceuticals Head office and Area Served
3.6 Global Key Players of Nutraceuticals, Product and Application
3.7 Global Key Players of Nutraceuticals, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nutraceuticals Breakdown Data by Type
4.1 Global Nutraceuticals Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Nutraceuticals Forecasted 麻豆原创 Size by Type (2025-2030)
5 Nutraceuticals Breakdown Data by Application
5.1 Global Nutraceuticals Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Nutraceuticals Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Nutraceuticals 麻豆原创 Size (2019-2030)
6.2 North America Nutraceuticals 麻豆原创 Size by Type
6.2.1 North America Nutraceuticals 麻豆原创 Size by Type (2019-2024)
6.2.2 North America Nutraceuticals 麻豆原创 Size by Type (2025-2030)
6.2.3 North America Nutraceuticals 麻豆原创 Share by Type (2019-2030)
6.3 North America Nutraceuticals 麻豆原创 Size by Application
6.3.1 North America Nutraceuticals 麻豆原创 Size by Application (2019-2024)
6.3.2 North America Nutraceuticals 麻豆原创 Size by Application (2025-2030)
6.3.3 North America Nutraceuticals 麻豆原创 Share by Application (2019-2030)
6.4 North America Nutraceuticals 麻豆原创 Size by Country
6.4.1 North America Nutraceuticals 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Nutraceuticals 麻豆原创 Size by Country (2019-2024)
6.4.3 North America Nutraceuticals 麻豆原创 Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Nutraceuticals 麻豆原创 Size (2019-2030)
7.2 Europe Nutraceuticals 麻豆原创 Size by Type
7.2.1 Europe Nutraceuticals 麻豆原创 Size by Type (2019-2024)
7.2.2 Europe Nutraceuticals 麻豆原创 Size by Type (2025-2030)
7.2.3 Europe Nutraceuticals 麻豆原创 Share by Type (2019-2030)
7.3 Europe Nutraceuticals 麻豆原创 Size by Application
7.3.1 Europe Nutraceuticals 麻豆原创 Size by Application (2019-2024)
7.3.2 Europe Nutraceuticals 麻豆原创 Size by Application (2025-2030)
7.3.3 Europe Nutraceuticals 麻豆原创 Share by Application (2019-2030)
7.4 Europe Nutraceuticals 麻豆原创 Size by Country
7.4.1 Europe Nutraceuticals 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Nutraceuticals 麻豆原创 Size by Country (2019-2024)
7.4.3 Europe Nutraceuticals 麻豆原创 Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Nutraceuticals 麻豆原创 Size (2019-2030)
8.2 China Nutraceuticals 麻豆原创 Size by Type
8.2.1 China Nutraceuticals 麻豆原创 Size by Type (2019-2024)
8.2.2 China Nutraceuticals 麻豆原创 Size by Type (2025-2030)
8.2.3 China Nutraceuticals 麻豆原创 Share by Type (2019-2030)
8.3 China Nutraceuticals 麻豆原创 Size by Application
8.3.1 China Nutraceuticals 麻豆原创 Size by Application (2019-2024)
8.3.2 China Nutraceuticals 麻豆原创 Size by Application (2025-2030)
8.3.3 China Nutraceuticals 麻豆原创 Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Nutraceuticals 麻豆原创 Size (2019-2030)
9.2 Asia Nutraceuticals 麻豆原创 Size by Type
9.2.1 Asia Nutraceuticals 麻豆原创 Size by Type (2019-2024)
9.2.2 Asia Nutraceuticals 麻豆原创 Size by Type (2025-2030)
9.2.3 Asia Nutraceuticals 麻豆原创 Share by Type (2019-2030)
9.3 Asia Nutraceuticals 麻豆原创 Size by Application
9.3.1 Asia Nutraceuticals 麻豆原创 Size by Application (2019-2024)
9.3.2 Asia Nutraceuticals 麻豆原创 Size by Application (2025-2030)
9.3.3 Asia Nutraceuticals 麻豆原创 Share by Application (2019-2030)
9.4 Asia Nutraceuticals 麻豆原创 Size by Region
9.4.1 Asia Nutraceuticals 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Nutraceuticals 麻豆原创 Size by Region (2019-2024)
9.4.3 Asia Nutraceuticals 麻豆原创 Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Nutraceuticals 麻豆原创 Size (2019-2030)
10.2 Middle East, Africa, and Latin America Nutraceuticals 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America Nutraceuticals 麻豆原创 Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Nutraceuticals 麻豆原创 Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Nutraceuticals 麻豆原创 Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Nutraceuticals 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America Nutraceuticals 麻豆原创 Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Nutraceuticals 麻豆原创 Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Nutraceuticals 麻豆原创 Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Nutraceuticals 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America Nutraceuticals 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Nutraceuticals 麻豆原创 Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Nutraceuticals 麻豆原创 Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Amway
11.1.1 Amway Company Details
11.1.2 Amway Business Overview
11.1.3 Amway Nutraceuticals Introduction
11.1.4 Amway Revenue in Nutraceuticals Business (2019-2024)
11.1.5 Amway Recent Developments
11.2 INFINITUS
11.2.1 INFINITUS Company Details
11.2.2 INFINITUS Business Overview
11.2.3 INFINITUS Nutraceuticals Introduction
11.2.4 INFINITUS Revenue in Nutraceuticals Business (2019-2024)
11.2.5 INFINITUS Recent Developments
11.3 Herbalife Nutrition
11.3.1 Herbalife Nutrition Company Details
11.3.2 Herbalife Nutrition Business Overview
11.3.3 Herbalife Nutrition Nutraceuticals Introduction
11.3.4 Herbalife Nutrition Revenue in Nutraceuticals Business (2019-2024)
11.3.5 Herbalife Nutrition Recent Developments
11.4 DEEJ
11.4.1 DEEJ Company Details
11.4.2 DEEJ Business Overview
11.4.3 DEEJ Nutraceuticals Introduction
11.4.4 DEEJ Revenue in Nutraceuticals Business (2019-2024)
11.4.5 DEEJ Recent Developments
11.5 Usana
11.5.1 Usana Company Details
11.5.2 Usana Business Overview
11.5.3 Usana Nutraceuticals Introduction
11.5.4 Usana Revenue in Nutraceuticals Business (2019-2024)
11.5.5 Usana Recent Developments
11.6 Blackmores
11.6.1 Blackmores Company Details
11.6.2 Blackmores Business Overview
11.6.3 Blackmores Nutraceuticals Introduction
11.6.4 Blackmores Revenue in Nutraceuticals Business (2019-2024)
11.6.5 Blackmores Recent Developments
11.7 PERFECT (CHINA)
11.7.1 PERFECT (CHINA) Company Details
11.7.2 PERFECT (CHINA) Business Overview
11.7.3 PERFECT (CHINA) Nutraceuticals Introduction
11.7.4 PERFECT (CHINA) Revenue in Nutraceuticals Business (2019-2024)
11.7.5 PERFECT (CHINA) Recent Developments
11.8 Swisse
11.8.1 Swisse Company Details
11.8.2 Swisse Business Overview
11.8.3 Swisse Nutraceuticals Introduction
11.8.4 Swisse Revenue in Nutraceuticals Business (2019-2024)
11.8.5 Swisse Recent Developments
11.9 China New Era Group
11.9.1 China New Era Group Company Details
11.9.2 China New Era Group Business Overview
11.9.3 China New Era Group Nutraceuticals Introduction
11.9.4 China New Era Group Revenue in Nutraceuticals Business (2019-2024)
11.9.5 China New Era Group Recent Developments
11.10 By-health
11.10.1 By-health Company Details
11.10.2 By-health Business Overview
11.10.3 By-health Nutraceuticals Introduction
11.10.4 By-health Revenue in Nutraceuticals Business (2019-2024)
11.10.5 By-health Recent Developments
11.11 Suntory
11.11.1 Suntory Company Details
11.11.2 Suntory Business Overview
11.11.3 Suntory Nutraceuticals Introduction
11.11.4 Suntory Revenue in Nutraceuticals Business (2019-2024)
11.11.5 Suntory Recent Developments
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Nutraceuticals Introduction
11.12.4 Pfizer Revenue in Nutraceuticals Business (2019-2024)
11.12.5 Pfizer Recent Developments
11.13 Beijing Tong Ren Tang
11.13.1 Beijing Tong Ren Tang Company Details
11.13.2 Beijing Tong Ren Tang Business Overview
11.13.3 Beijing Tong Ren Tang Nutraceuticals Introduction
11.13.4 Beijing Tong Ren Tang Revenue in Nutraceuticals Business (2019-2024)
11.13.5 Beijing Tong Ren Tang Recent Developments
11.14 Shanghai Pharma
11.14.1 Shanghai Pharma Company Details
11.14.2 Shanghai Pharma Business Overview
11.14.3 Shanghai Pharma Nutraceuticals Introduction
11.14.4 Shanghai Pharma Revenue in Nutraceuticals Business (2019-2024)
11.14.5 Shanghai Pharma Recent Developments
11.15 TIENS
11.15.1 TIENS Company Details
11.15.2 TIENS Business Overview
11.15.3 TIENS Nutraceuticals Introduction
11.15.4 TIENS Revenue in Nutraceuticals Business (2019-2024)
11.15.5 TIENS Recent Developments
11.16 GNC
11.16.1 GNC Company Details
11.16.2 GNC Business Overview
11.16.3 GNC Nutraceuticals Introduction
11.16.4 GNC Revenue in Nutraceuticals Business (2019-2024)
11.16.5 GNC Recent Developments
11.17 Real Nutriceutical
11.17.1 Real Nutriceutical Company Details
11.17.2 Real Nutriceutical Business Overview
11.17.3 Real Nutriceutical Nutraceuticals Introduction
11.17.4 Real Nutriceutical Revenue in Nutraceuticals Business (2019-2024)
11.17.5 Real Nutriceutical Recent Developments
11.18 Southernature
11.18.1 Southernature Company Details
11.18.2 Southernature Business Overview
11.18.3 Southernature Nutraceuticals Introduction
11.18.4 Southernature Revenue in Nutraceuticals Business (2019-2024)
11.18.5 Southernature Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Amway
INFINITUS
Herbalife Nutrition
DEEJ
Usana
Blackmores
PERFECT (CHINA)
Swisse
China New Era Group
By-health
Suntory
Pfizer
Beijing Tong Ren Tang
Shanghai Pharma
TIENS
GNC
Real Nutriceutical
Southernature
听
听
*If Applicable.